This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital discharge: ATC codes for adverse effects of drugs
ANY
Hospital Discharge: ICD-10
G70.0#
1 out of 7 registries used, show all original rules.
49
Check minimum number of events None
49
Include endpoints None
49
Remove individuals based on genotype QC
46
G6_MYASTHENIA_ADVERSE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5
Parent code in ICD-10
G70
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Myasthenia gravis, drug-induced
based on the number of shared cases.
Broader endpoints:
- Myasthenia gravis
- Diseases of the myoneural junction and muscle
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 46 | 32 | 14 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 43.81 | 38.59 | 55.72 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: G6_MYASTHENIA_ADVERSE – Myasthenia gravis, drug-induced
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Myasthenia gravis, drug-induced
↥Endpoint not on priority list, no data to show.